Friday, July 25, 2008

"Costly Cancer Drug Offers Hope, but Also a Dilemma"

Avastin is one of the most expensive drugs on the cancer market today. It can cost up to $100, 000 per year and despite its price, its popularity has increased. But is the drug worth its cost? Recent clinical reports show that Avastin might not increase life expectancy as much as the FDA thought, if it even helps at all. Read more about the drug here.

Why Women Aren’t C.E.O.s, According to Women Who Almost Were

"It’s not a pipeline problem. It’s about loneliness, competition and deeply rooted barriers." Read more in the NYT .